Section Arrow
Quote
KNSA.NASDAQ
- Kiniksa Pharmaceuticals International plc
Quotes are at least 15-min delayed:2025/07/05 03:09 EDT
Last
 27.88
+0.44 (+1.60%)
Day High 
27.92 
Prev. Close
27.44 
1-M High
30.69 
Volume 
558.08K 
Bid
26.7
Ask
27.88
Day Low
27.12 
Open
27.5 
1-M Low
26.54 
Market Cap 
2.00B 
Currency USD 
P/E 199.31 
%Yield -- 
10-SMA 28.14 
20-SMA 28.64 
50-SMA 26.94 
52-W High 30.69 
52-W Low 17.82 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.24/--
Enterprise Value
2.01B
Balance Sheet
Book Value Per Share
6.27
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
423.24M
Operating Revenue Per Share
3.41
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands0.5387+0.0535+11.03%-- 
RGCRegencell Bioscience Holdings Limited22.99+12.63+121.91%-- 
CGCCanopy Growth Corp1.28+0.09+7.56%-- 
IXHLIncannex Healthcare0.2094+0.0025+1.21%-- 
HLNHaleon plc10.25-0.01-0.10%23.95PE
Quotes are at least 15-min delayed：2025/07/05 03:09 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.